Last Posted: Jul 23, 2017
- I wish we'd known sooner about BRCA gene mutations
BC Selling, log post, Ovarian Cancer UK, 2017
- Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women
T Walsh et al, JAMA Oncology, July 20, 2017
- Study sheds light on the 'other' breast cancer genes
J Howard, CNN, July 21, 2017
- Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer.
Gamble Charlotte et al. Annals of surgical oncology 2017 Jul
- Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.
Manchanda Ranjit et al. American journal of obstetrics and gynecology 2017 Jul
- Large Study Verifies Cancer Risk for Women Carrying BRCA1 or BRCA2 Mutations
NCI, July 112, 2017
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Jul 1, 2017
- Page last updated:Jul 25, 2017
- Content source: